EPH Receptor B1 anticorps (C-Term)
Aperçu rapide pour EPH Receptor B1 anticorps (C-Term) (ABIN306671)
Antigène
Voir toutes EPH Receptor B1 (EPHB1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Attributs du produit
- Eph B1 (ELK receptor) cytoplasmic, Tyrosine-protein kinase receptor EPH-2, Ephrin type B receptor 1, HEK6,Myeloid tumor related gene (MTGR1) is found deleted in acute myeloid leukemia. Overexpression of MTGR1 can stimulate AML1-MTG8 to induce GCSF- dependent proliferation of L-G cells and to interfere with AML1- dependent transcription. AML1/MTG8 functions as a complex with MTGR1 and that the complex might be important in promoting leukemogenesis.
-
Purification
- Ammonium Sulfate Precipitation
-
Immunogène
- C terminal portion of recombinant protein
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Applications: Western Blot suggested dilution 1- 10 μg /mL
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Provided as solution in phosphate buffered saline with 0.08 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
-
-
- EPH Receptor B1 (EPHB1)
-
Autre désignation
- ELK rec tyr Kinase (Eph B1 Cy)
-
Pathways
- Signalisation RTK
Antigène
-